Latest News and Press Releases

Investor news Oncology Venture Investor Events in Q2 2019 Hørsholm, Denmark and Cambridge, MA, US, April 26th, 2019 – Oncology Venture A/S (“Oncology Venture”) today provided an update regarding...

Meddelande till investerare Oncology Venture investerarmöten under andra kvartalet 2019 Hørsholm, Danmark, 26 april, 2018 – Oncology Venture A/S (“Oncology Venture”) meddelar idag att VD Peter...

Meddelande til investererare Hoersholm, Danmark och Cambridge, MA, US, 26 april 2019 – Oncology Venture A/S meddelar idag att en artikel publicerad i Pharmagenomics förklarar hur DRP® kan ge...

Investor News Hørsholm, Denmark and Cambridge, MA, US, April 26, 2019 – Oncology Venture A/S announced today that an editorial published in Pharmagenomics explains how the DRP® can guide the...

Pressmeddelande Rättelse Felaktig MAR klassificering i tidigare pressmeddelande: Oncology Venture offentliggör idag ett tillägg till prospektet publicerat 5 april 2019 Hoersholm, Danmark och...

Press release Correction: MAR plate removed from this press release Oncology Venture today publishes a supplement to the prospectus published April 5, 2019 Oncology Venture A/S hereby announces...

Press release Oncology Venture A/S hereby announces a supplement to the prospectus published April 5, 2019 regarding a rights issue. As further described in the supplement, Oncology Venture A/S has...

Pressmeddelande Hoersholm, Danmark och Cambridge, MA, USA, 5 april 2019 – Oncology Venture A/S (”OV” eller ”Bolaget”) publicerar härmed ett tillägg till prospektet publicerat 5 april 2019 avseende...

Investor News Following the presentation of Oncology Venture’s prospectus as part of the rights issue announced on Friday, April 5, the company invites to a webcast. At the webcast, Oncology...

Meddelande till investerare Med anledning av att Oncology Venture fredagen den 5 april presenterade sitt prospekt som ett led i den aviserade företrädesemissionen bjuder bolaget in till en...